S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Comprehensive Analysis of PayPal Stock
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Comprehensive Analysis of PayPal Stock
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Comprehensive Analysis of PayPal Stock
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Comprehensive Analysis of PayPal Stock
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19

Vir Biotechnology (VIR) Earnings Date, Estimates & Call Transcripts

$7.95
-0.01 (-0.13%)
(As of 04/19/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 2
After Market Closes
Confirmed
Actual EPS
(Feb. 22)
-$0.86 Beat By $0.28
Consensus EPS
(Feb. 22)
-$1.14
Skip Charts & View Estimated and Actual Earnings Data

VIR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VIR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Vir Biotechnology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.99)($0.99)($0.99)
Q2 20242($1.34)($1.12)($1.23)
Q3 20242($1.35)($1.15)($1.25)
Q4 20241($0.99)($0.99)($0.99)
FY 20246($4.67)($4.25)($4.46)
Q1 20251($0.98)($0.98)($0.98)
Q2 20251($1.05)($1.05)($1.05)
Q3 20251($1.12)($1.12)($1.12)
Q4 20251($0.42)($0.42)($0.42)
FY 20254($3.57)($3.57)($3.57)

VIR Earnings Date and Information

Vir Biotechnology last released its quarterly earnings results on February 22nd, 2024. The reported ($0.86) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.14) by $0.28. The firm had revenue of $16.80 million for the quarter, compared to the consensus estimate of $11.18 million. Its quarterly revenue was down 66.0% on a year-over-year basis. Vir Biotechnology has generated ($4.59) earnings per share over the last year (($4.59) diluted earnings per share). Earnings for Vir Biotechnology are expected to grow in the coming year, from ($4.04) to ($3.87) per share. Vir Biotechnology has confirmed that its next quarterly earnings report will be published on Thursday, May 2nd, 2024. Vir Biotechnology will be holding an earnings conference call on Thursday, May 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call..

Vir Biotechnology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Confirmed)
-------  
2/22/2024Q4 2023($1.14)($0.86)+$0.28($0.86)$11.18 million$16.80 million    
11/2/2023Q3 2023($1.21)($1.22)($0.01)($1.22)$12.57 million$2.64 million
8/3/2023Q2 2023($1.21)($1.45)($0.24)($1.45)$22.39 million$3.80 million    
5/4/2023Q1 2023($0.86)($1.06)($0.20)($1.06)$50.10 million$63.00 million
2/23/2023Q4 2022($0.04)($0.76)($0.72)($0.76)$134.24 million$49.40 million
11/3/2022Q3 2022$0.01$1.30+$1.29$1.30$153.79 million$374.56 million
8/9/2022Q2 2022($0.17)($0.58)($0.41)($0.58)$211.14 million$40.60 million
5/5/2022Q1 2022$3.21$3.85+$0.64$3.85$811.05 million$1.20 billion    
2/24/2022Q4 2021$2.60$3.92+$1.32$3.92$622.90 million$812.75 million    
11/4/2021Q3 2021($0.30)$0.82+$1.12$0.82$138.25 million$103.62 million
8/5/2021Q2 2021($0.68)$0.46+$1.14$0.46$57.88 million$177.07 million  
5/6/2021Q1 2021($0.23)($1.32)($1.09)($1.32)$170.53 million$1.98 million  

Vir Biotechnology Earnings - Frequently Asked Questions

When is Vir Biotechnology's earnings date?

Vir Biotechnology has confirmed that its next quarterly earnings data will be published on Thursday, May 2nd, 2024. Learn more on VIR's earnings history.

Did Vir Biotechnology beat their earnings estimates last quarter?

In the previous quarter, Vir Biotechnology (NASDAQ:VIR) reported ($0.86) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.14) by $0.28. Learn more on analysts' earnings estimate vs. VIR's actual earnings.

How can I listen to Vir Biotechnology's earnings conference call?

The conference call for Vir Biotechnology's latest earnings report can be listened to online. Listen to Conference Call

How can I read Vir Biotechnology's conference call transcript?

The conference call transcript for Vir Biotechnology's latest earnings report can be read online. Read Transcript

How much revenue does Vir Biotechnology generate each year?

Vir Biotechnology (NASDAQ:VIR) has a recorded annual revenue of $86.18 million.

How much profit does Vir Biotechnology generate each year?

Vir Biotechnology (NASDAQ:VIR) has a recorded net income of -$615.06 million. VIR has generated -$4.59 earnings per share over the last four quarters.

What is Vir Biotechnology's EPS forecast for next year?

Vir Biotechnology's earnings are expected to grow from ($4.04) per share to ($3.87) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:VIR) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners